Key figures
2022 Highlights
2022 Revenue
| 2,405.3 Million euros |
+5.6% organic growth in 2022 |
Revenue by Region in 2022
| 17% Asia-Pacific |
40% Americas |
43% EMEA |
| In millions of euros | 2022 revenue | Contribution | Organic growth 2022/2021 | Total growth 2022/2021 |
|---|---|---|---|---|
| Europe, Middle East and Africa | 1,025.7 | 43% | 0% | 1.1% |
| Americas | 965.5 | 40% | 12% | 24.9% |
| Asia-Pacific | 414.1 | 17% | 9% | 15.3% |
| Full-Year Revenues | 2,405.3 | 100% | 5.6% | 12% |
Revenue by Audience in 2022
| 16.5% Doctors & Patients |
16% Citizens |
20.5% Clients & Employees |
47% Consumers |
| In million of euros | 2022 revenue | Contribution | Organic growth 2022/2021 |
|---|---|---|---|
| Consumers1 | 1,125.8 | 47% | 11% |
| Clients and employees2 | 495.1 | 20.5% | 6.5% |
| Citizens3 | 386.2 | 16% | -8.5% |
| Doctors and patients4 | 398.2 | 16.5% | 6% |
| Full-Year Revenues | 2,405.3 | 100% | 5,6% |
Breakdown of Service Lines by audience segment:
1- Brand Health Tracking, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market Strategy & Understanding, Observer (excl. public sector), Social Intelligence Analytics, Strategy3
2- Automotive & Mobility Development, Audience Measurement, Customer Experience, Channel Performance (including Retail Performance and Mystery Shopping), Media development, Capabilities
3- Public Affairs, Corporate Reputation
4- Pharma (quantitative and qualitative)
Summary consolidated financial statement
| In million of euros | 2022 | 2021 |
|---|---|---|
| Revenue | 2,405.3 | 2,146.7 |
| Gross profit | 1,594.1 | 1,389.3 |
| Operating margin | 314.7 | 277.4 |
| Adjusted net profit*, attributable to the Group | 232.4 | 209.2 |
| Workforce as of 31 December | 20,156 | 18,257 |
*Adjusted net profit is calculated before (i) non-cash items related to IFRS 2 (share-based compensation), (ii) amortisation of acquisition-related intangible assets (client relations), (iii) the impact net of tax of other noncurrent income, (iv) expense and the non-monetary impact of changes in puts in other financial income and expenses, (v) deferred tax liabilities related to goodwill for which amortisation is deductible in some countries.
Financial statement
| In million of euros | 2022 | 2021 |
|---|---|---|
| Total shareholders' equity | 1,500 | 1,342 |
| Financial debt | 69 | 181 |
| Free cash flow | 213.5 | 346 |
| Net debt / EBITDA | x 0,2 | x 0,5 |
| Net gearing | 4.6% | 13.4% |
Share capital and voting rights as at 31 December 2022
| Number of shares | % | Number of voting rights | % | |
|---|---|---|---|---|
| DT & Partners | 4,406,988 | 9.96 | 8,813,976 | 17.80 |
| Didier Truchot | 282,351 | 0.64 | 554,901 | 1.12 |
| Public | 38,406,482 | 86.79 | 38,501,122 | 77.73 |
| Employees | 1,024,969 | 2.32 | 1,659,736 | 3.35 |
| Including FCPE and Group savings plan | 15,650 | 0.04 | 31,300 | 0.063 |
| Treasury shares | 132,435 | 0.30 | 0 | 0.00% |
| Of which liquidity agreement | 9,364 | 0.02 | 0 | 0.00% |
| Total | 44,253,225 | 100 | 49,529,735 | 100 |